OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-09-30-accounts

Trustees Mrs Michaela
M Rees
Jones
Mr Maunce
H Craft
Mr Jonathan S M Craft
Mr Percy Beckley
Mr Laurence J F Tarlo
Mrs R L Craft (Appointed 10November
2022)
Ambassadors Mrs Cheryl Whitehead
Ms Tiffany Chawner
Ms Nicola Floyd
Mr Julian
O'Dell
Patrons Lord Alliance CBE
Harry &Carolyn
Black
Barry Boas
Roger Cadbury
Family
Harold
& Daphne Cooper Charitable
Trust
Peter & Marilyn Cooper
John Emery
Alassandro
Dusi
Isabel Ettedgui
The Fallon
Family
Leonard &Ranee Feinstein
Charles & Diane Herlinger
Michael & Lottie Hunter
Bob Lefroy
Bevs Mahm
Martin
O'Connor
Sir Michael Parkinson CBE
Sir Paul & Lady Ruddock
Ivor & Isabelle Seddon
Chns Sharp
Michaela
M Ress Jones
Secretary Mrs Joyce Fletcher (J.P.)
Charity number 1143743
Company number 07767248
Principal address 2 Regency Chambers
Jubilee Way
Bury
Lancashire
BL9OJW
Registered office 2 Regency Chambers
Jubilee Way
Bury
Lancashire
BL9OJW

Page
Chairman's statement
Trustees' report 2-7
Statement ofTrustees' responsibilities
Independent
auditor's
report 9-11
Statement offinancial actwities 12-13
Balance sheet 14
Statement ofcash flows 15
Notes to the finanaal statements 16-24

Unrestricted Restricted Total Total
funds funds
Notes 2022
f
2022f 2022f 2021f
Income from:
Voluntary
income
3 464,027 37,194 501,221 279,706
Investments 4 7,005 7,005 9,628
Total income 471,032 37,194 508,226 289,334
~Ed i
Raising funds 5 71,907 71,907 69,459
Charitable
activities
6 339,665 138,067 477,732 1,028,978
Total 411,572 138,067 549,639 1,098,437
Net income/(expenditure) for the year)
Net movement in funds 59,460 (100,873) (41,413) (809,103)
Fund balances at 1 October 2021 2,111,856 113,150 2,225,006 3,034,109
Fund balances st 30September 2022 2,171,316 12,277 2,183,593 2,225,006

Prior financial year
Unrestricted Restricted Total
funds funds
2021 2021 2021
Notes 8 8
Income from:
Voluntary
income
226,039 53,667 279,706
Investments 9,628 9,628
Total income 235,667 53,667 289,334
~Ed i
Raising funds 5 69,459 69,459
Chantable
activities
8 1,013,959 15,019 1,028,978
Total 1,083,418 15,019 1,098,437
Net income/(expenditure) for the year/
Net movement in funds (847,751) 38,648 (809,103)
Fund balances at 1 October 2020 2,959,607 74,502 3,034,109
Fund balances at 30September 2021 2,111,856 113,150 2,225,006

2022 2021
Notes 5 6
Current assets
Debtors 391 381
Cash at bank and in hand 2,239,418 2,302,991
2,239,809 2,303,372
Creditors: amounts falling due within
one year 12 (56,216) (78,366)
Net current assets 2,183,593 2,225,006
Funds ofthe charity
Restricted funds 13 12,277 113,150
Unrestncted funds.
General unrestncted funds 658,197 641,903
Designated funds 14 1,513,119 1,469,453
2,183,593 2,225,006

2022 2021
Notes 6 6
Cash flows from operating activities
Cash absorbed
by operations
17 (70,578) (839,998)
Investing activities
Investment income received 7,005 9,628
Net cash
activities
generated
from
investing 7,005 9,628
Net cash used
in financing
activities
Net decrease
in cash and
cash equivalents (63,573) (830,370)
Cash and cash equivalents at beginning ofyear 2,302,991 3,133,361
Cash and cash equivalents at end of year 2,239,418 2,302,991

N0
N
CIC Ch
Yl
0
I
ID
CD
ID
CD
0
Dl
N
'D
Ot
II
IO
CO
N0 Ol IA
IA
N
CD
5
IA IA
IO
Ol
'a8 IO
CO
N0
N
Ctt CO
CD
IA
IA
I
CO
0
CD
N
IO
D
80 N
N0
N
CIC N
N
CD
0
0
0
IAN
N
0
IA
'U
Ot
D
Ol
CO0
I
N
N0
N
Cll C
CO
0
0
0
IAN
CO
CA
IO
IO
CO3
I
Ol
0
N
CV0
N
III 0
CD
N
0I
CD
IO
0 IO0
LUI-
z0I-
z
cL'aZ
po
0
V)
ized
OlO
Nl
Ill
LU
IXI Cl
LUI-
—~ cC
~ LUrn
z U
Ueo
Z &
I-oz
z
LL~g
~ Ng LL
I~
Q.
O
0
CI
CO Q
& g UJ
~z
L tO Qt
Dt
4~a
iOrn
LU I- 8-
ZUO
I- cL'z
4l
0
0 IO
IO0
0
Cl
Vl
tO
C
tt

4 Investments Investments
Unrestricted Unrestricted
funds funds
2022 2021
f
Interest receivable 7,005 9,628
5 Raising funds
Unrestricted Unrestricted
funds funds
2022f 2021
5
Costs of generating voluntary income
Travelhng and subsistence 112
Printing, stationery and postage 1,091 1,130
Fundraising
expenses
463
Other expenses 298 177
Advertising 475 445
Other fundraising costs 615 266
Staff costs 67,958 66,594
Insurance 895 847
Costs of generating voluntary income 71,907 69,459

Unrestricted Restricted TotalUnrestricted TotalUnrestricted Restricted Total
2022 2022
5
2022
6
2021
6
2021
5
2021f
LMTK3 drug development 91,781 91,781 308,789 308,789
Cancer stem cells research 100,873 100,873
PhD and other student
bursaries 64,622 64,622 99,393 99,393
Ovarian cancer research 12,627 12,627 23,094 23,094
Pancreatic cancer research 25,238 25,238 14,808 14,808
Genetic switches 66,530 66,530 134,508 134,508
Breast cancer research 73,850 37,194 111,044 428,075 15,019 443,094
Other research project 232 232
334,648 138,067 472,715 1,008,899 15,019 1,023,918
Share ofgovernance costs
(see note 7) 5,017 5,017 5,060 5,060
339,665 138,067 477,732 1,013,959 15,019 1,028,978
Analysis
by fund
Unrestricted
funds
339,665 339,665 1,013,959 1,013,959
Restricted
funds
138,067 138,067 - 15,019 15,019
339.665 138,067 477,732 1,013,959 15,019 1,028,978

2022 2021
Number Number
Management
Employment costs 2022
f
2021
f
Wages and salaries 64,250 62,720
Social secunty costs 2,425 2,591
Other pension costs 1,283 1,283
67,958 66,594
No employees had annual remuneration off60,000or more.
Many of the research proiects involve the use of PhD students. Action Against Cancer is currently funding
a
number
of PhD studentships
and fellowships
at Imperial
College to support the research work.
10 Taxation
The charity
is
exempt from tax on income and gains falling within section 505 ofthe Taxes Act 1988or section
252 ofthe Taxation of Chargeable Gains Act 1992to the extent that these are applied to its charitable objects.
11 Debtors
2022 2021
Amounts
falling due
within one year: f
Prepayments and accrued income 391 381

Creditors: a m oun ts falling due within o ne year
2022 2021
E E
Trade creditors 54,422 76,808
Other creditors 1,794 1,558
56,216 78,366
Restricted funds
The income funds of the charity include restricted funds comprising the following unexpended balances
of
donations and grants held on trust for specific purposes:
Movement in funds Movement in funds
Balance at Income Expenditure Balance at Income Expenditure Balance at
1 October 2020 1 October 2021 30 September
2022
E E E
Cancer stem
cells research 59,483 53,667 113,150 (100,873) 12,277
Breast cancer
research 15,019 (15,019) 37,194 (37,194)
74,502 53,667 (15,019) 113,150 37,194 (138,067) 12,277

15 Analysis ofnet assets between funds
Unrestricted Restricted Total Unrestricted Restricted Total
funds funds funds funds
2022 2022 2022 2021 2021 2021
8 6 6 F 6
Fund balances at 30
September 2022 are
represented
by:
Current assets/(liabilities) 2,171,316 12,277 2,183,593 2,111,856 113,150 2,225,006
2,171,316 12,277 2,183,593 2,111,856 113,150 2,225,006

Cash generated
from
operations 2022 2021
6
Deficit for the year (41,413) (809,103)
Adjustments for:
Investment income recognised in statement of finanaal activities (7,005) (9,628)
Movements in working capital.
(Increase) in debtors (10)
(Decrease) in creditors (22,150) (21,267)
Cash absorbed
by operations
(70,578) (839,998)